1-19 of 19
Ingrid Mayer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P4-12-01: Adherence with adjuvant endocrine therapy with or without Palbociclib in the PALLAS trial

Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux, Jun Mao, Vesna Bjelic-Radisic, Michelle Naughton, Georg Pfeiler, Karen Gelmon, Ingrid Mayer, Daniel Egle, Gabriele Zoppoli, Tiffany Traina, Miguel Martin Jiménez, Silvia Antolin Novoa, Tufia Haddad, Arlene Chan, Alistair Edward Ring, Antonio Wolff, Jose JuanPonce Lorenzo, Dhanusha Sabanathan, Hal Burstein, Zbigniew Ireneusz Nowecki, Gunda Pristauz-Telsnigg, Adam Brufsky, Meritxell Bellet-Ezquerra, Theodoros Foukakis, Yelena Novik, Gabor Rubovszky, Karoline Muehlbacher, Otto Metzger, Theodora Goulioti, Ernest Law, Ann Partridge, Lisa Carey, Alex Zoroufy, Dominik Hlauschek, Christian Fesl, Erica Mayer, Michael Gnant
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P4-12-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P4-12-01
Published: 15 February 2022
View article
Journal Articles

Abstract PD13-01: Balixafortide (a CXCR4 antagonist)+eribulin versus eribulin alone in patients with HER2 negative, locally recurrent or metastatic breast cancer: An international, randomized, phase 3 trial (FORTRESS)

Peter Kaufman, Miguel Martin, Ingrid Mayer, Linda Vahdat, Sonia Pernas, Peter Schmid, Heather McArthur, Rebecca Dent, Hope S Rugo, Carlos Barrios, Alexandra Bobirca, Francois Ringeisen, Daniela Schmitter, Javier Cortes
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD13-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD13-01
Published: 15 February 2022
View article
Journal Articles

Abstract OT1-10-02: I-SPY2 endocrine optimization protocol (EOP): A pilot neoadjuvant endocrine therapy study with amcenestrant as monotherapy or in combination with abemacicilib or letrozole in molecularly selected HR+/HER2- clinical stage 2/3 breast cancer

A. Jo Chien, Kevin M Kalinsky, Julissa Molina-Vega, Rita Mukhtar, Karthik Giridhar, Olufunmilayo I Olopade, Amrita Basu, Smita M Asare, Paul Henderson, Gillian Hirst, Ruixiao Lu, Ella Jones, Nola Hylton, Lamorna Brown-Swigart, Laura J van 't Veer, Douglas Yee, Ingrid Mayer, Laura J Esserman
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-10-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-OT1-10-02
Published: 15 February 2022
View article
Journal Articles

Abstract PS7-34: The association of race and socioeconomic status with overall survival in women with breast cancer in the southern community cohort study

Sonya Reid, Lucy B Spalluto, Diane Haddad, Tuya Pal, Ingrid Mayer, Xiao-ou Shu, Wei Zheng, Maureen Sanderson, William Blot, Loren Lipworth
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS7-34.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS7-34
Published: 15 February 2021
View article
Journal Articles

Abstract PS10-35: Early intervention for and management of alpelisib (ALP)-induced hyperglycemia: Case studies from the phase III SOLAR-1 trial

Ingrid Mayer, Azeez Farooki, Hope S. Rugo, Hiroji Iwata, Eva Ciruelos, Mario Campone, Sibylle Loibl, Pierfranco Conte, Dejan Juric, Farhat Ghaznawi, Ines Lorenzo, Huilin Hu, Fiorenza Gaudenzi, Fabrice Andre
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS10-35.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS10-35
Published: 15 February 2021
View article
Journal Articles

Abstract PD2-05: Randomized phaseII trial to evaluate alisertib alone or combined with fulvestrant for advanced, endocrine-resistant breast cancer (TBCRC 041)

Tufia Haddad, Antonino D'Assoro, Vera Suman, Jodi Carter, Brendan McMenomy, Erica Mayer, Meghan Karuturi, Aki Morikawa, Paul Marcom, Claudine Isaacs, Sun Young Oh, Amy Clark, Ingrid Mayer, Khandan Keyomarsi, Roberto Leon-Ferre, Karthik Giridhar, Ciara O'Sullivan, Prema Peethambaram, Timothy Hobday, Minetta Liu, James Ingle, Matthew Goetz
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD2-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD2-05
Published: 15 February 2021
View article
Journal Articles

Abstract OT-33-01: Combination ipatasertib and atezolizumab to prevent recurrence in triple negative breast cancer(TNBC): A phase II single arm trial

Elizabeth Mittendorf, Sara Tolaney, Paul Wileyto, Michelle DeMeo, Hope Rugo, Rita Nanda, Ingrid Mayer, Ben Park, Heather MacArthur, Angela DeMichelle
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-33-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-OT-33-01
Published: 15 February 2021
View article
Journal Articles

Abstract OT1-08-06: International, phase 3 trial: Balixafortide (a CXCR4 antagonist) + eribulin versus eribulin alone in patients with HER2 negative, locally recurrent or metastatic breast cancer (FORTRESS) international, phase 3 trial: Balixafortide (a CXCR4 antagonist) + eribulin versus eribulin alone in patients with HER2 negative, locally recurrent or metastatic breast cancer (FORTRESS)

Peter Kaufmann, MD, Javier Cortes, MD, PhD, Miguel Martin, MD, PhD, Ingrid Mayer, MD, Linda Vahdat, MD, Sonia Pernas, MD, PhD, Peter Schmid, MD, PhD, Heather McArthur, MD, Rebecca Dent, MD, Hope Rugo, MD, Carlos Barrios, MD, Debra Barker, MD, Barbara Romagnoli, PhD, Alexandra Bobirca, MD
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT1-08-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-OT1-08-06
Published: 15 February 2020
View article
Journal Articles

Abstract CT128: Palbociclib in combination with fulvestrant or tamoxifen as treatment for hormone receptor positive metastatic breast cancer with prior chemotherapy for advanced disease (TBCRC 035): A Phase II study with pharmacodynamic markers

Hope S. Rugo, Erica Mayer, Anna Maria Storniolo, Claudine Isaacs, Ingrid Mayer, Vered Stearns, Rita Nanda, Julie Nangia, Michelle Melisko, Chiara Wabl, Alona Muzikansky, Bose Kochupurakkal, Ben H. Park, Antonio Wolff, Geoffrey Shapiro
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT128.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT128
Published: 01 July 2019
View article
Journal Articles

Abstract CT142: Prevalence of PIK3CAmutations in patients with hormone receptor-positive, human epidermal growth factor-2-negative advanced breast cancer from the SOLAR-1 trial

Hope S. Rugo, Ingrid Mayer, Pierfranco Conte, Sibylle Loibl, Mario Campone, Dejan Juric, Fabrice Andre, Marilyn Fritzemeier, Wei He, Naveen Babbar, Eva Ciruelos
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT142.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT142
Published: 01 July 2019
View article
Journal Articles

Abstract 2427: Patterns of BRCA testing by provider type based on biological and non-biological factors among a diverse sample of young breast cancer survivors

Sonya Reid, Deborah Cragun, Ann Tezak, Anne Weidner, Ingrid Mayer, Xiao-ou Shu, Susan Vadaparampil, Tuya Pal
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2427.
DOI: https://doi.org/10.1158/1538-7445.AM2019-2427
Published: 01 July 2019
View article
Journal Articles

Correction: Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast Cancer

Neil E. Bhola, Valerie M. Jansen, Sangeeta Bafna, Jennifer M. Giltnane, Justin M. Balko, Mónica V. Estrada, Ingrid Meszoely, Ingrid Mayer, Vandana Abramson, Fei Ye, Melinda Sanders, Teresa C. Dugger, Eliezer V. Allen, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2019) 79 (4): 876.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-4088
Published: 15 February 2019
View article
PDF
Journal Articles

Abstract 1410: PI3K inhibitors reduce breast cancer tumor growth and enhance anti-tumor leukocyte activity

Nicole Lavender, Jinming Yang, Jiqing Sai, Sergey Novitskiy, Linda Horton, Andrew Johnson, Vandana Abramson, Ingrid Mayer, Ingrid Meszoely, Mark Kelley, Ann Richmond
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1410.
DOI: https://doi.org/10.1158/1538-7445.AM2016-1410
Published: 15 July 2016
View article
Journal Articles

Abstract CT231: A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with estrogen receptor+ HER2-, advanced/metastatic breast cancer

Maura Dickler, Aditya Bardia, Ingrid Mayer, Eric Winer, Peter Rix, Jeff Hager, Meng Chen, Iris Chan, Edna Chow-Maneval, Carlos Arteaga, Jose Baselga
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): CT231.
DOI: https://doi.org/10.1158/1538-7445.AM2015-CT231
Published: 01 August 2015
View article
Journal Articles

Abstract OT1-1-13: A Phase 2, randomized, open-label, multicenter, safety and efficacy study of oral lucitanib in patients with metastatic breast cancer with alterations in the FGF pathway

Maysa Abu-Khalaf, Ingrid Mayer, Jason B Litten, Mitch Raponi, Andrew R Allen, Lajos Pusztai, Carlos L Arteaga
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): OT1-1-13.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-OT1-1-13
Published: 01 May 2015
View article
Journal Articles

Abstract P5-19-24: Phase Ib/II study of LEE011 and BYL719 and letrozole in ER+, HER2– breast cancer: Safety, preliminary efficacy and molecular analysis

Dejan Juric, Erika Hamilton, Laura Garcia Estévez, Richard H De Boer, Ingrid Mayer, Mario Campone, Shizuka Asano, Suraj Bhansali, Vickie Zhang, Becker Hewes, Pamela Munster
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-19-24.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P5-19-24
Published: 01 May 2015
View article
Journal Articles

Abstract PD6-3: Recurrent ESR1 fusion transcripts are associated with endocrine resistance in estrogen receptor positive, HER2 negative breast cancer

Jennifer M Giltnane, Justin M Balko, Thomas L Stricker, Christian Young, M Valeria Estrada, Nikhil Wagle, Eliezer van Allen, X Jasmine Mu, Violeta Sanchez, Jaime Farley, Kerry Fitzgerald, Armin Graber, Joseph A Pinto, Franco Doimi, Henry Gómez, Monica Rizzo, Thomas B Julian, Vandana Abramson, Ingrid Mayer, Mark Kelley, Ashwini Yenamandra, Ferrin C Wheeler, Melinda Sanders, Levi Garraway, Ingrid Meszoely, Carlos L Arteaga
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD6-3.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-PD6-3
Published: 01 May 2015
View article
Journal Articles

Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast Cancer

Neil E. Bhola, Valerie M. Jansen, Sangeeta Bafna, Jennifer M. Giltnane, Justin M. Balko, Mónica V. Estrada, Ingrid Meszoely, Ingrid Mayer, Vandana Abramson, Fei Ye, Melinda Sanders, Teresa C. Dugger, Eliezer V. Allen, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2015) 75 (2): 405–414.
DOI: https://doi.org/10.1158/0008-5472.CAN-14-2475
Published: 14 January 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 2934: Genomic alterations associated with resistance to antiestrogens identified by multiplatform molecular analysis in operable ER+ breast cancer

Jennifer M. Giltnane, Justin Balko, Jasmine Mu, Jason Christiansen, Danielle Murphy, Ingrid Mayer, Ingrid Meszoely
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2934.
DOI: https://doi.org/10.1158/1538-7445.AM2014-2934
Published: 01 October 2014
View article